Probity Advisors, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Probity Advisors, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$512,877
+49.0%
39,635
+60.0%
0.11%
+49.3%
Q1 2024$344,180
+10.8%
24,779
+13.8%
0.07%
+4.4%
Q4 2023$310,772
+14.9%
21,778
+24.5%
0.07%
+9.7%
Q3 2023$270,539
+17.7%
17,488
+19.5%
0.06%
+24.0%
Q2 2023$229,916
+17.5%
14,635
+16.6%
0.05%
+13.6%
Q4 2022$195,749
+24.7%
12,548
+3.8%
0.04%
+12.8%
Q3 2022$157,00012,0930.04%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders